12th Annual Outsourcing in Clinical Trials Nordics 2024

The annual meeting place for pharmaceutical, biotechnology, and medical device communities in the Nordics to network and discuss strategies for operational success in clinical trials

1 - 2

October

2024
  • Clarion Hotel & Congress Copenhagen Airport, Denmark
  • Complimentary
  • Why attend?
  • Agenda
  • Speakers
  • Plan Your Visit
  • Event Gallery
  • Sponsors
  • Media Centre
  • Why partner?
  • Contact Us
close

Why attend?

WHAT TO EXPECT FOR 2024?

200+

Attendees

30+

Exhibitors

30+

Speakers

200+

Attendees

30+

Exhibitors

30+

Speakers

See What It's All About

Agenda

  • 1 Oct 2024
  • 2 Oct 2024
Expand All

Streams

Stream one

OUTSOURCING IN CLINICAL TRIALS & CLINICAL OPERATIONS

7:30 AM

Registration and refreshments

8:15 AM

Chairperson’s opening remarks

Speakers

Helen Johansen Blanco
Chief Operating Officer, Node Pharma A/S

8:30 AM

Sharing latest updates to the Clinical Trial Regulation (CTR) and Clinical Trial Information System (CTIS)

• Providing latest updates: what’s new from the EU regulatory framework?
• Learning from previous submissions: tips and tricks

Speakers

Lene Grejs Petersen
Senior Advisor, Danish Medicines Agency

9 AM

Reserved for Medidata

9:30 AM

Building an Outsourcing Strategy for your clinical trials

• Initiation: landscaping and defining the project
• Strategy development: analyses and stakeholder management
• Implementation: selecting vendors, training and alignment
• Maintenance: KPIs and governance
• Tips and tricks to consider

Speakers

Rikke Winther
Outsourcing Specialist, Camurus AB

Streams

Stream one

OUTSOURCING IN CLINICAL TRIALS & CLINICAL OPERATIONS

Stream two

CLINICAL TRIALS TECHNOLOGY & INNOVATION

8:15 AM

Registration and refreshments

8:45 AM

Chairperson’s Opening Remarks

Speakers

Helen Johansen Blanco
Chief Operating Officer, Node Pharma A/S

9 AM

Navigating through the jungle of regulatory requirements for combination trials

  • Overview of the COMBINE project created to analyse challenges and find solutions for combined studies
  • Reviewing key regulatory factors within CTR, MDR and IVD to ensure compliance
  • Best practice for streamlining your submissions to optimise approvals for parallel submissions

Speakers

Ditte Zerlang Andersen
Senior EU Project Lead, Senior Adviser, Danish Medicines Agency

9:30 AM

Reserved for event sponsor

10 AM

Improving sustainability: Healthcare transition into a Net Zero world

  • Healthcare sector’s responsibility and action to address the climate crisis as accelerator for the health crisis
  • Methodology and available tools to assess carbon footprint of clinical trials
  • Clinical best-practices to save significant natural and financial resources

Speakers

Morten Pedersen
VP, Head of Clinical Operations, Lundbeck

10:30 AM

Morning Refreshments & Networking

11 AM

Re-evaluating your study if things go wrong in clinical trial: to stay or change?

  • Pro-actively preparing for the worst up front
  • Considerations for changing or re-assessing sites
  • Assessing, selecting and switching vendors: benefits and challenges
  • Case study example: success and lessons learnt

Speakers

Helen Johansen Blanco
Chief Operating Officer, Node Pharma A/S

11:30 AM

Reserved for event sponsor

12 PM

Case Study: Successfully outsourcing a trial from a small to mid-size biotech perspective

  • Selecting vendors suitable for smaller companies
  • Managing the trial and oversight with a small biotech team and limited resource
  • Overcoming hurdles and sharing best practice to successfully outsource trial

Speakers

Stina Westergaard Frederiksen
Senior Director and Head of Clinical Operations, Y-mAbs Therapeutics A/S

12:30 PM

Lunch and networking

1:30 PM

PI overview of patient safety when carrying out digital elements and decentralized clinical trials

  • Outlining role of the Principal Investigator in digital and decentralized clinical trials
  • Considering key strategies for ensuring patient safety and maintaining regulatory compliance
  • Sharing examples of benefits and challenges of digital integration

Speakers

John Zibert
Chief Medical Officer, Coegin Pharma

2 PM

Fireside Chat: How to de-risk a clinical development program?

  • Value of obtaining early feedback from Key Opinion Leaders and Regulators
  • Risk assessment at the trial level
  • Trial oversight matrix implemented with all vendors and subcontractors

Speakers

Anna Polak
Head of Clinical Trials, Cyxone

2:30 PM

Afternoon refreshments, networking and prize draw

3 PM

ROUNDTABLE SESSIONS

During the roundtable discussion session, the conference hall will be divided into zones. Delegates can choose which zone they would like to join. Each zone will be led by a table moderator and will focus on a different challenge within the industry. After 30 minutes, delegates will have the opportunity to swap and choose a different table, and each roundtable will run twice.

Roundtable 1
Mitigating risk in clinical supply chain
Pernille Hemmingsen, Chief Technology Officer, Adcendo

Roundtable 2
Increasing patient enrolment and engagement in clinical trials

Roundtable 3
Considering DCT trial design and impact on both the patient and company

4 PM

End of conference

8:45 AM

Chairperson’s opening remarks

Speakers

Libbi Rickenbacher
Senior Director Product Strategy and Partnerships, 4G Clinical

9 AM

Case Study: Real world example of Artificial Intelligence in clinical development – PoC to Production

  • Understanding regulation and preparing compliance
  • Driving innovation and technology into processes through use of generative AI
  • Implementing AI for practical use with valuable return on investment

Speakers

Stephen Lutsch
Senior Director Clinical Trial Digital Innovation, Genmab

9:30 AM

Reserved for event sponsor

10 AM

Case Study: Accelerating innovation through digital health technology solutions

  • Driving true benefits for clinical research through digital health technology
  • Learnings from barriers created by integration of digital health
  • Improving processes and focusing on delivering digital health as a tool

Speakers

Magnus Jörntén-Karlsson
Head of Digital Patient & Site Technology, Evinova at AstraZeneca

10:30 AM

Morning Refreshments & Networking

11 AM

Expert Conversation: Strategic Considerations for End-to-End Development of Fit-For-Purpose Digital Measures of Health

  • Strategies for sourcing components from a scattered ecosystem
  • How to develop meaningful, human-centric measures
  • Pitfalls and opportunities for analytical and clinical validation
  • Novel solutions and digital pathways for scalable regulatory qualification
  • Maximizing value: how to repurpose and extend solutions across use cases in R&D and healthcare

Speakers

Kai Langel
CEO, DEEP Measures

11:30 AM

Reserved for event sponsor

12 PM

Transforming clinical trials: ideas from leading industry professionals

  • Assessing outcomes from over 70 interviews with life science industry pioneers
  • Reviewing what clinical professionals wish would be different in the life sciences industry
  • Suggesting next steps towards further evolving clinical trials

Speakers

Ivanna Rosendal
Senior Director, IT Business Partner, Ascendis Pharma

12:30 PM

Lunch and networking

1:30 PM

Maintaining control and oversight of data in outsourced trials

  • Considering, generally and specifically, data collected with eDiary, CGM and other external sources
  • Assessing risks when outsourcing trials
  • Acting accordingly to manage and mitigate risks
  • Maintaining right level of oversight

Speakers

Ane Jensen
Principal Data Manager, Zealand Pharma

2 PM

Panel Discussion: Considering existing and emerging technology to assist with clinical trials

  • Digitalization: what can we digitalize to improve systems and processes
  • AI: what can we implement to save time and resource
  • Systems: what technology and systems are available and emerging to assist in clinical trials and data management

 

Speakers

Libbi Rickenbacher
Senior Director Product Strategy and Partnerships, 4G Clinical
Stephen Lutsch
Senior Director Clinical Trial Digital Innovation, Genmab
Ane Jensen
Principal Data Manager, Zealand Pharma

2:30 PM

Afternoon refreshments, networking and prize draw

10 AM

Reserved for Worldwide Clinical Trials

10:30 AM

Morning Refreshments & Networking

11 AM

Creating functional partnerships between sponsors and CROs in a volatile world

  • Integrating vendors and silos into your own organization
  • Considering where vendor management ends and vendor oversight starts?
  • Creating the right framework for a long-lasting partnership

Speakers

Lars Rosendal
Former Head of Global Clinical Operations, LEO Pharma

11:30 AM

Why so slow? Insider insights from the clinic floor to speed up the startup and execution of proof-of-concept patient trials

How to:

  • Harness regulatory dynamics for strategic advantages.
  • Obtain feasibility figures true to delivery.
  • Employ innovative study designs to expedite the development program.
  • Customize efficient patient recruitment tactics!

Speakers

Dr. Claudia Hesselmann
Founder and CEO, ARENSIA Exploratory Medicine

12 PM

Panel Discussion: Negotiating vendor agreements: getting the right balance for both sponsor and vendor

  • Finding the right balance between the needs of sponsor company and vendor to ensure right fit
  • Negotiating contracts: costs vs vendor ability to perform
  • Forging partnerships and relationships to enhance contract negotiations and communication

Moderator: Helen Johansen Blanco, Chief Operating Officer, Node Pharma A/S

Speakers

Helen Johansen Blanco
Chief Operating Officer, Node Pharma A/S

12:30 PM

Reserved for Langland

1 PM

Lunch and networking

2 PM

Clinical trial outsourcing: a customer perspective

  • Clinical trial outsourcing strategies
  • Sponsor company expectations and CRO selection
  • Clinical trial oversight – considerations for finding the right balance between efficiency and safety

Speakers

Christopher Burton
Chief Medical Officer, Reponex Pharmaceuticals A/S

2:30 PM

Reserved for TFS Healthscience

3 PM

Developing neuroimaging and CNS drug: preparing for clinical trial

  • Sharing insights on collaborations with clinical CROs on previous clinical studies
  • Preparing for a clinical trial with a University Hospital in Denmark
  • Choosing and developing the right trial design

Speakers

Christine Ryan
Chief Operating Officer, Gabather

3:30 PM

Afternoon refreshments and networking

4 PM

Clinical Trial Investigations: Looking at the trends and landscape for 2023 and what we can learn from them

  • Overview of global clinical trials for 2023
  • Assessing key sponsors, top interventions and looking at the trial landscape for 2023
  • Looking at key obstacles for terminated trials and evaluation of completed trials which have achieved endpoint status

Speakers

Priya Nair
Senior Analyst, GlobalData

4:30 PM

Reserved for event sponsor

5 PM

Panel Discussion: Defining effective governance structures and oversight models

  • Creating an efficient governance structure to suit the study
  • Communicating and monitoring the framework
  • Evaluating needs and wants of both sponsor and vendor companies
  • Sharing best practice for governance oversight

Speakers

Helen Johansen Blanco
Chief Operating Officer, Node Pharma A/S
Caroline Sandstroem
Head of Global Clinical Quality, Ferring Pharmaceuticals
Anna Polak
Head of Clinical Trials, Cyxone

5:30 PM

Chairperson’s closing remarks

Speakers

Helen Johansen Blanco
Chief Operating Officer, Node Pharma A/S

END OF DAY 1 AND NETWORKING DRINKS

Speakers

Select a speaker to learn more

Back
Ivanna Rosendal
Senior Director, IT Business Partner, Ascendis Pharma

Session Details:

Transforming clinical trials: ideas from leading industry professionals

2024-10-02, 12:00 PM

View In Agenda

Social Links:

Next speaker
Back
Magnus Jörntén-Karlsson
Head of Digital Patient & Site Technology, Evinova at AstraZeneca

Session Details:

Case Study: Accelerating innovation through digital health technology solutions

2024-10-02, 10:00 AM

View In Agenda
Next speaker
Back
Rikke Winther
Outsourcing Specialist, Camurus AB

Rikke Winther has worked in the CRO and Pharmaceutical industry for the past 30 years and has experience from Clinical R&D, Business Development and Contract/Outsourcing Management. She built up and headed up Lundbeck group of Outsourcing & Contracts Management R&D for 19 years and has for the past 4 years worked as an clinical outsourcing specialist for smaller biopharma and covers CRO selection processes as well as contractual, operational and relationship related activities with clinical CROs.

She has in earlier part of her career within bio-analytical research and clinical development in hospital settings as well as project management and business development management at a clinical CRO in Europe and Asia.

Rikke is a former member of the Steering Committee member of the Pharmaceutical Contract Management Group (PCMG) for many years and is a contributing author of the book: “Outsourcing Clinical Development, Gower Publishing Limited”.

 

Session Details:

Building an Outsourcing Strategy for your clinical trials

2024-10-01, 9:30 AM

Session Details:

Building an Outsourcing Strategy for your clinical trials

2024-10-01, 9:30 AM

View In Agenda
Next speaker
Back
John Zibert
Chief Medical Officer, Coegin Pharma

Dr. John Zibert, Chief Medical Officer Coegin Pharma AB, a listed Nordic biotech company with several unique molecular technologies and compounds , where he also serves as CEO of Avexxin Oncology AS and Board Member of Reccura Therapeutics AS. He received his master's in medicine and human biology, and PhD in immunology at the University of Copenhagen, DK and University of Otago, NZ. He has demonstrated a successful history of working in the pharmaceutical and digital healthcare industry in established corporate businesses, and in an incubator co-establishing more than 25 start-ups within digital health and biotech, and several of his own biotech companies. Furthermore, he has an academic footprint of 79 publications in particular within digital health, tumor biology and dermatology. He has a deep experience within execution of drug research and development, Decentralized Clinical Trials, digital healthcare solutions, and leadership.

Session Details:

PI overview of patient safety when carrying out digital elements and decentralized clinical trials

2024-10-02, 1:30 PM

View In Agenda
Next speaker
Back
Lene Grejs Petersen
Senior Advisor, Danish Medicines Agency

Lene Grejs Petersen is Senior Adviser at the Danish Medicines Agency, Clinical Trial Unit. Lene is member of the Clinical Trials Coordinating and Facilitation Group (CTCG) member since 2008 and is the Danish representative of the EU Commission’s expert group concerning clinical trials (CTEG) since 2001. Lene has been an employee at the Danish Medicines Agency since 2000 and she has been involved in the implementation of the EU Clinical Trials Regulation into Danish legislation and works as a regulatory assessor and coordinator of clinical trials. Lene has a background as Master in Pharmacy.

Session Details:

Sharing latest updates to the Clinical Trial Regulation (CTR) and Clinical Trial Information System (CTIS)

2024-10-01, 8:30 AM

Session Details:

Sharing latest updates to the Clinical Trial Regulation (CTR) and Clinical Trial Information System (CTIS)

2024-10-01, 8:30 AM

View In Agenda
Next speaker
Back
Ditte Zerlang Andersen
Senior EU Project Lead, Senior Adviser, Danish Medicines Agency

Session Details:

Navigating through the jungle of regulatory requirements for combination trials

2024-10-02, 9:00 AM

View In Agenda
Next speaker
Back
Caroline Sandstroem
Head of Global Clinical Quality, Ferring Pharmaceuticals

Dr. Caroline Sandström received her PhD in Medical Science from Lund University, Sweden in 2008. She has then worked for Novo Nordisk A/S, Denmark for several years as a pharmacologist driving and executing pharmacological plans supporting pre-clinical projects.

Her interest and enthusiasm for project management, continuous improvement, streamlining initiatives and training was then later beneficially used when she moved into the compliance area managing global improvement and training initiatives within R&D Quality Management System (QMS) including Clinical. For example, she was the project manager for implementing the effective use of Root Cause Analysis in Clinical Development activities but also being highly involved in initiatives related to Quality Culture.  Ferring Pharmaceuticals A/S in Copenhagen, DK. On a daily basis she was involved in discussing, driving compliance and improvement initiatives within both Non-Clinical, Clinical and Pharmacovigilance related activities. She has taken a very active role in contributing to a collaborative and transparent organization where sharing learnings are a main focus area.

From beginning of May 2022, she moved into the position of being Head of the Global Clinical Quality Department being responsible for the QA support of global key stakeholder areas such as Clinical Development, Regulatory Affairs, Pharmacovigilance and Discovery. Her scientifically driven problem-solving skills are used for implementing global cross-functional initiatives, and for supporting and strengthening the harmonization and quality mindset in the organization.

Session Details:

Assessing vendor categories to improve governance and accountabilities across clinical trial activities

2023-10-25, 1:30 PM

Session Details:

Panel Discussion: Defining effective governance structures and oversight models

2024-10-01, 5:00 PM

View In Agenda
Next speaker
Back
Christine Ryan
Chief Operating Officer, Gabather

Dr Christine Natasha Ryan holds a PhD in Neuroscience from the University of Cambridge, Cambridge, UK and an MBA from Stockholm School of Economics. Following a post-doc at the Brain Research Institute, St. Hans Hospital, Roskilde, Denmark, Dr Ryan remained in Scandinavia moving to Sweden to work at Astra, which then became AstraZeneca, holding line management and competitive intelligence roles. Dr Ryan has engaged in preclinical research at blue chip companies such as AstraZeneca, smaller pharmaceutical companies, CROs and biotechs, working at Karo Bio AB, and Cerca Insights among others. Dr Ryan joined Gabather AB as Principal Scientist in 2017, becoming VP Operations in 2018. She is currently COO.

Session Details:

Developing neuroimaging and CNS drug: preparing for clinical trial

2024-10-01, 3:00 PM

View In Agenda
Next speaker
Back
Stephen Lutsch
Senior Director Clinical Trial Digital Innovation, Genmab

In my position as Senior Director - Clinical Trial Digital Innovation at Genmab, I lead a team driving AI adoption within clinical operations, decentralized clinical trials and digital innovation in drug development. Previously, I have been working to bring the best disruptive innovation into normal clinical operations at LEO Pharma to help improve and accelerate their clinical trials. Furthermore, I am trying to solve some of the toughest challenges related to scaling digitalization, data, and automation to generate competitive advantages across business units. One aspect is driving the necessary foundational components around a scalable GxP data platform, machine learning opportunities as well as automating digital processes with robotics process automation. Besides leading the necessary change internally, focus is on a design-thinking approach where we put the patient and site at the center. I have an ambition towards “delighting” patients, investigators, and sponsors by solving the real-world challenges they face by leveraging both qualitative interviews and observation, as well as quantitative methods to reveal actionable insights

Session Details:

Case Study: Real world example of Artificial Intelligence in clinical development – PoC to Production

2024-10-02, 9:00 AM

Session Details:

Panel Discussion: Considering existing and emerging technology to assist with clinical trials

2024-10-02, 2:00 PM

View In Agenda
Next speaker
Back
Priya Nair
Senior Analyst, GlobalData

Session Details:

Clinical Trial Investigations: Looking at the trends and landscape for 2023 and what we can learn from them

2024-10-01, 4:00 PM

View In Agenda
Next speaker
Back
Lars Rosendal
Former Head of Global Clinical Operations, LEO Pharma

Session Details:

Creating functional partnerships between sponsors and CROs in a volatile world

2024-10-01, 11:00 AM

View In Agenda
Next speaker
Back
Morten Pedersen
VP, Head of Clinical Operations, Lundbeck

Morten completed his Master’s degree in Biotechnology at National University of Ireland, Galway, in 1997, specializing in Pharmacology. He joined Lundbeck in August 2020 as VP, Head of Clinical Operations.

Career to date Morten started at a CRO in 1997 as a CRA on an Epilepsy study.  In the subsequent years he worked in CRO’s, consultancy and big Pharma taking on roles within Project Management, Program Oversight, Innovation and Strategic Partnerships.  He joined Pfizer in 2003 and has a wide range of project management experience delivering projects across multiple therapeutic areas. From 2007 to 2011 he held a leadership role in Pfizer’s Clinical Study Management group providing Operational Oversight in various outsourcing models.  As Group Lead of Emerging Markets and Established Products Business Units he managed a team of Program Directors in a variety of Therapy Areas from Phase II to Late Phase and Non-Interventional trials. From late 2011 Morten joined an Innovation technology CRO in the role of Senior Director and Head of Strategic Partnerships with the aim of improving Clinical Trial efficiencies and supporting Trial Sites. In August 2016 he joined InVentiv Health as VP, Head of Program Delivery in Neuroscience, before the group merged with INC to become Syneos Health.

 

Session Details:

Improving sustainability: Healthcare transition into a Net Zero world

2024-10-02, 10:00 AM

View In Agenda
Next speaker
Back
Helen Johansen Blanco
Chief Operating Officer, Node Pharma A/S

Helén Johansen Blanco has 20+ years of clinical development experience, managing Phase I to III clinical trials leading to the successful launch of several oncology products. She has experience in project management of large global clinical trials conducted in all continents of the world, mainly within oncology, but also therapeutic areas as cardiovascular and gastrointestinal. Mrs. Blanco has previously worked for large international pharma companies such as Astra Zeneca and Mylan, as well as small, medium to large sized biotechnology companies as Nordic Nanovector and Celgene, in addition to smaller and larger CROs such as Smerud and Covance. Currently she holds a position as Head of Clinical Operations at Oncoinvent, a small medium sized biotech company located in Norway. She holds a MSc in Biophysics and medical technology from Norwegian Technology and Science University and is currently writing her thesis for a Master in Business Administration.

Session Details:

Chairperson’s Opening Remarks

2024-10-02, 8:45 AM

Session Details:

Panel Discussion: Negotiating vendor agreements: getting the right balance for both sponsor and vendor

2024-10-01, 12:00 PM

Session Details:

Chairperson’s closing remarks

2024-10-01, 5:30 PM

Session Details:

Re-evaluating your study if things go wrong in clinical trial: to stay or change?

2024-10-02, 11:00 AM

Session Details:

Panel Discussion: Defining effective governance structures and oversight models

2024-10-01, 5:00 PM

View In Agenda
Next speaker
Back
Christopher Burton
Chief Medical Officer, Reponex Pharmaceuticals A/S

Session Details:

Clinical trial outsourcing: a customer perspective

2024-10-01, 2:00 PM

View In Agenda
Next speaker
Back
Stina Westergaard Frederiksen
Senior Director and Head of Clinical Operations, Y-mAbs Therapeutics A/S

Session Details:

Case Study: Successfully outsourcing a trial from a small to mid-size biotech perspective

2024-10-02, 12:00 PM

View In Agenda
Next speaker
Back
Ane Jensen
Principal Data Manager, Zealand Pharma

Ane H. Jensen (MA)

Passionate about new technology and their ability to change the way we conduct clinical trials. Has worked at different positions in Novo Nordisk between 2008 and 2020. Since 2020 employed at Zealand Pharma. Previous experiences include RTSM, training, process improvements, logistics, clinical trials supplies and eLearning development.

Session Details:

Maintaining control and oversight of data in outsourced trials

2024-10-02, 1:30 PM

Session Details:

Panel Discussion: Considering existing and emerging technology to assist with clinical trials

2024-10-02, 2:00 PM

View In Agenda
Next speaker
Back
Anna Polak
Head of Clinical Trials, Cyxone

Session Details:

Panel Discussion: Defining effective governance structures and oversight models

2024-10-01, 5:00 PM

Session Details:

Fireside Chat: How to de-risk a clinical development program?

2024-10-02, 2:00 PM

View In Agenda
Next speaker
Back
Dr. Claudia Hesselmann
Founder and CEO, ARENSIA Exploratory Medicine

Dr. Claudia Hesselmann, a chemist by training, with a PhD in molecular biology. Claudia has twenty years of expertise in the early phases of drug development. Her experience includes co-founding and holding management positions in various CROs. Her extensive background and social acumen, along with her first-hand knowledge of the industry, led Claudia to co-found ARENSIA Exploratory Medicine in Düsseldorf, Germany. Her primary aim is the contribution of innovative approaches to bring about substantial acceleration to the drug development process and enable more agile patient access to novel therapeutics.

Session Details:

Why so slow? Insider insights from the clinic floor to speed up the startup and execution of proof-of-concept patient trials

2024-10-01, 11:30 AM

View In Agenda
Next speaker

Plan Your Visit

Venue

Clarion Hotel & Congress Copenhagen Airport

Clarion Hotel & Congress Copenhagen Airport, Kastrup,Denmark, 2770

To reserve your discounted room please send an email to: reservation.cl.copenhagen.airport@strawberry.dk and put in the booking number in the Subject: 3034GR035734 • Discounted accommodation at Clarion Hotel Copenhagen Airport is available at a price per night of DKK 1,495 inclusive of VAT.

Accommodation

Arena International Events Group “(Arena”) is aware of numerous third party agencies which are contacting Arena’s customers and purporting to have access to hotel room bookings and events attendee lists. For the avoidance of doubt, Arena will only share attendee lists with carefully selected third party partners for event registration purposes. Whilst Arena International Events Group pursues third party agencies for their potentially illicit activity, Arena encourages you to be cautious in engaging with such third party agencies and Arena shall not accept any responsibility for any losses incurred by you should you choose to engage with third parties that have no affiliation to Arena International Events Group.

Sponsors

Select a sponsor to learn more

FEATURED SPONSORS

SESSION SPONSORS

TECHNOLOGY SHOWCASE SPONSOR

DRINKS RECEPTION

EXHIBITOR

Why partner?

 

Contact us to become a partner

Partnership Opportunities

We work with you to design a bespoke package to meet your business needs, where you could:

  • Demonstrate your expertise on the agenda – have the attention of the entire audience. For greatest impact, why not position your talk before a networking break and immediately conduct follow up conversations with highly engaged attendees
  • Showcase your business and its services at an exhibition booth, which provides a perfect meeting place for prospective new clients
    Present the value proposition of your offering over your competitors, in front of an audience of active, engaged potential customers
  • Speak with key decision makers as part of our intimate, interactive roundtable style workshop sessions with over 8 hours allowed for networking

Event reach

  • 200+ attendees each year
  • 80% attendees C-suite level

 

Take a look at our current sponsors

Media Centre

MEDIA PARTNERS

Become A Media Partner

Enquiry

Contact Us

SPONSORSHIP ENQUIRIES

Alex Purnell

Senior Sponsorship Manager

+44 204540 7786

SPEAKER ENQUIRIES

Ruth Atterbury

Portfolio Manager

+44 (0) 20 4540 7796

MARKETING ENQUIRIES

Moona Popal

Marketing Manager

DELEGATE ENQUIRIES

Sunny Saikia

VIP Delegate Manager

SPONSORSHIP ENQUIRIES

To enquire about sponsorship opportunities for the conference, please contact:

Alex Purnell

Senior Sponsorship Manager


+44 204540 7786

SPEAKER ENQUIRES

To enquire about speaking opportunities for the conference, please contact:

Ruth Atterbury

Portfolio Manager


+44 (0) 20 4540 7796